Intratumoral Versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?

Intratumoral Versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?

The molecular and cell determinants that modulate immune checkpoint (ICI) efficacy in lung cancer are still not well understood. However, there is a necessity to select those patients that will most benefit from these new treatments. Recent studies suggest the presence and/or the relative balance of...

Full description

Bibliographic Details
Main Authors: Marta Gascón, Dolores Isla, Mara Cruellas, Eva M. Gálvez, Rodrigo Lastra, Maitane Ocáriz, José Ramón Paño, Ariel Ramírez, Andrea Sesma, Irene Torres-Ramón, Alfonso Yubero, Julián Pardo, Luis Martínez-Lostao
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Cells
Subjects:
biomarkers
lung cancer
immune cells in cancer
tumor microenvironment
immune checkpoints inhibitors
Online Access:https://www.mdpi.com/2073-4409/9/6/1525

Internet

https://www.mdpi.com/2073-4409/9/6/1525

Similar Items